Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse

DOI: 10.1038/s41591-019-0593-1

Brief report on the clinical characteristics of patients whose samples generate small cell lung cancer circulating tumour cell derived explants

DOI: 10.1016/j.lungcan.2020.11.002

EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancer

DOI: 10.21037/tlcr-20-1061

Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection

DOI: 10.1002/1878-0261.13150

Plasticity of circulating tumor cells in small cell lung cancer. 

DOI: 10.1038/s41598-023-38881-5

Challenges of small cell lung cancer heterogeneity and phenotypic plasticity

DOI: 10.1038/s41568-025-00803-0

EORTC 1417 – REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer

DOI: 10.1016/j.ejca.2025.116059

Early Dissemination of Circulating Tumor Cells: Biological and Clinical Insights

DOI: 10.3389/fonc.2021.672195